Table 1 Baseline characteristics of participants according to SBP-TTR.
TTR < 25% n = 3422 | 25% ≤ TTR < 50% n = 1448 | 50% ≤ TTR < 75% n = 1508 | TTR ≥ 75% n = 1360 | P value | |
|---|---|---|---|---|---|
Age (years) | 61.36 ± 10.68 | 56.33 ± 10.19 | 54.50 ± 10.67 | 52.17 ± 10.49 | < 0.001 |
Male, No. (%) | 2785 (81.39) | 1197 (82.67) | 1244 (82.49) | 1126 (82.79) | 0.547 |
SBP (mmHg) | 156.90 ± 18.62 | 142.91 ± 17.54 | 139.80 ± 14.76 | 133.65 ± 9.23 | < 0.001 |
BMI (kg/m2) | 25.83 ± 3.31 | 25.75 ± 3.19 | 25.73 ± 3.12 | 25.78 ± 3.18 | 0.668 |
FBG (mmol/L) | 6.32 ± 1.88 | 6.24 ± 1.87 | 6.10 ± 1.79 | 5.95 ± 1.66 | 0.041 |
LDL-c (mmol/L) | 2.97 ± 0.84 | 2.94 ± 0.81 | 3.00 ± 0.80 | 2.95 ± 0.77 | 0.001 |
HDL-c (mmol/L) | 1.42 ± 0.39 | 1.40 ± 0.36 | 1.42 ± 0.38 | 1.41 ± 0.37 | 0.002 |
Hs-CRP (mg/dl) | 1.20 (0.30, 2.40) | 1.10 (0.10, 2.26) | 1.00 (0.10, 2.02) | 0.99 (0.10, 2.04) | 0.002 |
SBP-mean (mmHg) | 154.30 ± 12.29 | 139.35 ± 9.04 | 134.30 ± 6.81 | 130.28 ± 4.20 | < 0.001 |
eGFR (mL/min·1.73 m2) | 86.22 ± 16.24 | 89.74 ± 16.54 | 92.80 ± 16.51 | 94.03 ± 16.35 | < 0.001 |
cIMT (mm) | 0.90 (0.80, 1.10) | 0.90 (0.80, 1.00) | 0.90 (0.80, 1.00) | 0.80 (0.80, 0.90) | < 0.001 |
CAPs, No. (%) | 547 (15.98) | 145 (10.01) | 139 (9.22) | 99 (7.28) | < 0.001 |
Smoking, No. (%) | 1182 (34.54) | 589 (40.68) | 623 (41.31) | 604 (44.41) | < 0.001 |
Drinking, No. (%) | 987 (28.84) | 447 (30.87) | 491 (32.56) | 486 (35.74) | < 0.001 |
Exercising, No. (%) | 832 (24.31) | 287 (19.82) | 339 (22.48) | 317 (23.31) | < 0.001 |
Diabetes mellitus, No. (%) | 532 (15.55) | 204 (14.09) | 180 (11.94) | 151 (11.10) | < 0.001 |
Antihypertensive medications, No. (%) | 1821 (53.21) | 562 (38.81) | 473 (28.98) | 332 (24.41) | < 0.001 |
Antidiabetic agents, No. (%) | 197 (5.76) | 70 (4.83) | 51 (3.38) | 47 (3.46) | < 0.001 |
Lipid-lowering drugs, No. (%) | 118 (3.45) | 42 (2.90) | 39 (2.59) | 43 (3.16) | < 0.001 |
High school and above, No. (%) | 682 (19.93) | 286 (19.75) | 336 (22.28) | 384 (28.24) | < 0.001 |
